AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H951. A total of 4 filers reported holding AMYLYX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,440,723 | -28.0% | 133,300 | -15.1% | 0.01% | -27.3% |
| Q2 2023 | $3,388,647 | +25.1% | 157,100 | +70.2% | 0.01% | +10.0% |
| Q1 2023 | $2,708,082 | +27.9% | 92,300 | +61.1% | 0.01% | +100.0% |
| Q4 2022 | $2,117,235 | -72.7% | 57,300 | -79.2% | 0.01% | -66.7% |
| Q3 2022 | $7,758,000 | +933.0% | 275,600 | +606.7% | 0.02% | +1400.0% |
| Q2 2022 | $751,000 | – | 39,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 39,000 | $751,000 | 0.00% |
| SIMPLEX TRADING, LLC | 5,600 | $107,000 | 0.00% |
| JANE STREET GROUP, LLC | 12,900 | $248,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |